OurCrowd earns $200m from BioCatch exit
Globes
The Jerusalem-based venture capital fund made what is probably its most profitable-ever exit on Visa’s acquisition of BioCatch.
GlobesGlobesThe Jerusalem-based venture capital fund made what is probably its most profitable-ever exit on Visa’s acquisition of BioCatch.